New functions for non-collagenous domains of human collagen type IV - Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo

Citation
E. Petitclerc et al., New functions for non-collagenous domains of human collagen type IV - Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo, J BIOL CHEM, 275(11), 2000, pp. 8051-8061
Citations number
59
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
275
Issue
11
Year of publication
2000
Pages
8051 - 8061
Database
ISI
SICI code
0021-9258(20000317)275:11<8051:NFFNDO>2.0.ZU;2-J
Abstract
Collagen type IV is a major component of the basal lamina of blood vessels. Six genetically distinct collagen type IV chains have been identified and are distributed in a tissue-specific manner. Here we define a novel functio n for soluble non-collagenous (NC1) domains of the alpha 2(TV), alpha 3(IV) , and alpha 6(IV) chains of human collagen type IV in the regulation of ang iogenesis and tumor growth. These NC1 domains were shown to regulate endoth elial cell adhesion and migration by distinct alpha(v) and beta(1) integrin -dependent mechanisms. Systemic administration of recombinant alpha 2(IV), alpha 3(IV), and alpha 6(IV) NC1 domains potently inhibit angiogenesis and tumor growth, whereas alpha 1(TV), alpha 4(TV), and alpha 5(IV) showed litt le if any effect. These findings suggest that specific NC1 domains of colla gen type IV may represent an important new class of angiogenesis inhibitors .